Aging
Navigate
Back to articleFigure 8(8 of 8)
100%
Figure 8
Figure 8.Effect of m7G risk score on chemotherapy sensitivity. (AL) AZD7762, Paclitaxel, Nilotinib, JNK Inhibitor VIII, JNK.9L, GSK269962A, Gefitinib, FTI.277, Docetaxel, Cyclopamine, Camptothecin, Bicalutamide.
Figure 8 — Integrative analyses reveal biological function and prognostic role of m7G methylation regulators in high-grade glioma | Aging